July 11, 2024

Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI

BY Erica Goodpaster
Artificial Intelligence, Blogs, Business, Digital Pathology News, Pathology News

paigeFrom the NVIDIA blog. Paige Cofounder sits down with AI Podcast’s Noah Kravits to discuss potential changes AI could bring to healthcare.

Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Paige cofounder and Chief Scientific Officer Thomas Fuchs. He’s also dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.

Tune in to hear Fuchs on machine learning and AI applications and how technology brings better precision and care to the medical industry.

Time Stamps

1:03: Background on Paige and computational pathology
7:28: How AI models use visual pattern recognition to accelerate cancer detection
11:27: Paige’s results using AI in cancer imaging and pathology
15:16: Challenges in cancer detection
17:38: Thomas Fuchs’ background in engineering at JPL and NASA
24:10: AI’s future in the medical industry

Subscribe to the AI Podcast

Get the AI Podcast through iTunes, Amazon Music, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.

SOURCE: NVIDIA

OR
back to news

platinum partners

gold partners

Silver Partners

Media Partners

become a partner
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing